What Are the Requirements for GLP-1 Medications?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight management for millions, with clinical trials showing an average weight loss of 15-22% over 68 weeks. Before beginning semaglutide or tirzepatide, patients need to meet specific medical and clinical requirements to ensure safety and effectiveness. PlexusDx streamlines this qualification process with a telehealth-first approach that connects you to licensed healthcare providers.

Medical History and Health Screening Requirements

Your healthcare provider will review your complete medical history before prescribing GLP-1 medications. This includes current medications, previous surgeries, and any chronic conditions like diabetes, heart disease, or thyroid disorders. Full transparency about your health status helps providers identify potential interactions or contraindications that could affect your safety on GLP-1 therapy.

Certain conditions require extra caution or may make GLP-1 treatment inappropriate. Personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe pancreatitis are key red flags. PlexusDx providers conduct thorough screening during your initial consultation to determine if semaglutide injection or another GLP-1 option aligns with your health profile.

Blood pressure monitoring and kidney function assessment are often part of baseline screening. Patients with significantly elevated creatinine levels or severe kidney disease may need dose adjustments or alternative approaches. Your provider uses this baseline data to set a safe starting dose and establish follow-up monitoring intervals.

Weight Loss Goals and BMI Eligibility Criteria

GLP-1 medications are typically prescribed to adults with a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions. Weight-related comorbidities include type 2 diabetes, hypertension, sleep apnea, and cardiovascular disease. PlexusDx evaluates both your BMI and your overall metabolic health to determine the best treatment fit.

Having realistic weight loss expectations strengthens treatment success. Most patients benefit from GLP-1 therapy when they commit to lifestyle changes alongside medication—dietary modifications, regular movement, and stress management amplify results. PlexusDx providers discuss your specific goals during qualification to ensure alignment with what GLP-1 treatment can realistically achieve.

Some patients qualify for GLP-1 therapy based on metabolic risk factors even if they fall slightly below the standard BMI cutoff. Insulin resistance, prediabetes, or elevated inflammatory markers can influence eligibility. Your PlexusDx provider considers the complete clinical picture, not BMI alone.

Telehealth Consultation and Provider Evaluation Process

PlexusDx connects you with licensed healthcare providers who conduct comprehensive virtual consultations. During your first visit, the provider reviews your medical questionnaire, discusses your weight history, and assesses your readiness for GLP-1 treatment. This telehealth-first model eliminates travel barriers and reduces time between consultation and prescription.

Your provider will ask about previous weight loss attempts, current lifestyle patterns, and any concerns about side effects. Open communication helps them select the most appropriate GLP-1 option—whether that is compounded semaglutide injection starting at $149/month, oral semaglutide, or a dual-compound protocol. The goal is matching the right medication and delivery method to your preferences and clinical needs.

Follow-up visits establish ongoing accountability and safety monitoring. PlexusDx providers check in on your progress, side effects, and dosing adjustments as you continue therapy. This continuous care model ensures you remain on track and can address emerging questions or concerns without waiting weeks for an appointment.

Lab Work and Genetic Testing for Precision Treatment

Baseline lab work typically includes fasting glucose, hemoglobin A1c, lipid panel, liver function, and kidney function markers. These results establish your metabolic baseline and help your provider choose the safest starting dose. PlexusDx providers order these labs through partner laboratories, often covered by HSA/FSA accounts even without insurance.

The Precision Peptide Genetic Test offered by PlexusDx adds a personalization layer by analyzing 14 metabolic pathways and 150+ genetic insights tied to GLP-1 response. Key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 influence how your body responds to semaglutide or tirzepatide. Available as a $99 add-on after your first month of treatment, this test helps optimize your long-term protocol.

Genetic insights combined with clinical labs create a true precision medicine approach. Instead of trial-and-error dosing, PlexusDx can identify which GLP-1 compound, delivery method, and dose trajectory aligns with your genetic profile. This science-backed personalization maximizes efficacy and minimizes unnecessary adjustments.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need insurance to qualify for GLP-1 treatment at PlexusDx?

No. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization. Your compounded semaglutide injection starts at $149/month with no hidden costs, and most patients can use HSA or FSA funds to pay. This direct-to-patient model keeps pricing transparent and treatment accessible.

What happens if I have type 2 diabetes—does that change GLP-1 eligibility?

Type 2 diabetes is a strong indicator for GLP-1 therapy because these medications lower blood sugar while promoting weight loss. Your provider will adjust your diabetes medications if needed to prevent dangerously low blood sugar levels. PlexusDx providers have extensive experience managing GLP-1 treatment in diabetic patients and coordinate closely with your existing care.

How long does the PlexusDx qualification process take?

Most patients complete their initial telehealth consultation and receive their first prescription within 24-48 hours. PlexusDx uses licensed 503A compounding pharmacies to prepare your medication, ensuring both safety and speed. You can begin your GLP-1 journey without prolonged delays or bureaucratic waiting periods.

Are compounded GLP-1 medications from PlexusDx safe and regulated?

Yes. All PlexusDx medications come from licensed 503A compounding pharmacies that follow strict FDA oversight and quality standards. While compounded medications are not FDA-approved, they are created under rigorous pharmaceutical regulations. PlexusDx only partners with accredited facilities that maintain purity, sterility, and potency guarantees.

Can the Precision Peptide Genetic Test predict my weight loss results?

The Precision Peptide Genetic Test analyzes 49 peptides across 14 metabolic pathways to predict your response patterns to semaglutide or tirzepatide. While genetics is one factor, lifestyle adherence and individual metabolism also influence outcomes. The test helps PlexusDx providers optimize your medication choice and dosing strategy for your unique peptide profile, increasing the likelihood of meaningful weight loss.

Related Reading

• Glp 1 Medications
• Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications
• Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications
• Maximus Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.